The sam® sustained acoustic medicine device from ZetrOZ Systems will be showcased at the 15th annual TOBI Orthobiologic Symposium from June 20-22 at Caesar’s Palace in Las Vegas. The symposium is in collaboration with the American Society of Interventional Pain Physicians.
ZetrOZ Systems will be at booth number #319, featuring the sam® X1 wearable ultrasound unit available for purchase by physicians and medical professionals in bundles of four or more for their practice.
Dr. Jason Krystofiak will present the latest research on sustained acoustic medicine for soft tissue healing in a talk titled “Long Duration Ultrasound (LDU) for the Treatment of Knee Osteoarthritis and Low Back Pain: RCTs,” at 4:20 p.m. on Saturday, June 22, followed by an “Ask Us Anything” panel discussion with Dr. Adam Telmonde.
Dr. Krystofiak is the division chief of Sports Medicine at Cooperman Barnabas Medical Center in Livingston, N.J., and medical director of Sports Medicine and medical director of the Matthew J. Morahan III Health Assessment Center for Athletes at RWJBarnabas Health. He also serves as a team physician for Rutgers University and the lead physician for the Rutgers football team.
Dr. Krystofiak recently led a webinar on the TOBI Network entitled “Enhancing PRP Results with sam® Wearable Ultrasound,” with host Dr. Rowan Paul, a pioneer in the field of regenerative orthopedics. The study, published in August 2023 in the journal Orthopedic & Muscular System: Current Research, examined the recovery of 35 elite college athletes who had suffered injuries to the tendons of the leg, knee, or wrist during the 2022-2023 season.
The results showed that athletes treated with a combination of PRP and long-duration ultrasound with the sam® 2.0 device returned to play 21.3 days more quickly than those receiving only PRP treatment. Additionally, these athletes reported experiencing less pain and better overall health. Six months later, examinations found that the treatment had no adverse effects on healing.
“The combination of PRP+LDU therapy provides a significant reduction in time to return to sport without impacting the long-term durability of the soft tissue. It increases pain reduction and overall health improvement for patients recovering from a sport-related injury,” Krystofiak and his co-authors concluded.
Krystofiak’s study joins the body of research – now more than 40 studies in peer-reviewed publications – that have found sustained acoustic medicine to be effective in treating a wide range of soft tissue injuries. ZetrOZ Systems’ sam® devices are the only FDA-cleared, long-duration ultrasound treatment for prescription home use and have successfully treated hundreds of thousands of patients.
“We’re grateful to The Orthobiologic Institute and American Society of Interventional Pain Physicians for providing a platform to share advancements in this field,” said George K. Lewis, CEO of ZetrOZ Systems, biomedical engineer and the inventor of sustained acoustic medicine.
“Our technology has allowed physicians and other health care providers to help hundreds of thousands of patients heal without the need for pain medication or invasive procedures. Sharing this information with the pioneers and thought leaders in their field will bring our treatment to even more people who could benefit from it.”
